Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
|Live BSE Quotes||Oct 26, 2016 09:24:00 AM|
|Price (Rs)6,105.90||Open (Rs) 6,105.90||High (Rs) 6,105.90||Low (Rs) 6,105.90|
|% Change0.03||Volume 3||Value (Rs) 18,318||52-Week H/L 6,800.00 / 5,366.50|
|Live NSE Quotes||Oct 26, 2016 9:24:59 AM|
|Price (Rs)6,056.50||Open (Rs) 6,106.60||High (Rs) 6,110.55||Low (Rs) 6,052.15|
|% Change-0.82||Volume 279||Value (Rs) 1,694,096||52-Week H/L 6,800.00 / 5,405.00|
|EPS (Rs)* 164.65||P/E Ratio (x) 37.08||Market Cap (Rs m) 256,814.15||P/BV (x) 10.50|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|GSK CONSUMER Stock Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
GSK Consumer Healthcare has announced the first quarter results of the financial year 2016-2017 (1QFY17). The company's sales declined by 1.4% YoY while net profit rose by 2.9% YoY during the quarter.
GSK Consumer Healthcare announced its results for the quarter and year ended March 2016. During the quarter, sales and profit came in lower by 9% YoY and 8% YoY respectively.
GSK Consumer Healthcare announced its results for the quarter ended December 2015. While revenues were up by 2% YoY, profits were higher by 37% YoY.
ITC declared results for the quarter and year ended March 2016. During the year, the company's net revenues and profits rise by 1% YoY and 3% YoY respectively.
Dabur announced its results for the quarter ended March 2016. The company reported a revenue growth of 11% YoY during the quarter, while profits moved up by 17% YoY.More Views on News
A brief discussion on one BHK apartments going for Rs 1.8 crore in Mumbai and why it makes no sense.
Are we really on our way to becoming the 'India of our dreams'?
Apurva talks about his Secret Profit Signal and his first ever training session
PersonalFN explains why top performing mutual fund schemes may not always be the perfect fit for your investment portfolio.
Why the PE ratios of mid caps and small caps are currently at such lofty levels.More